FIELD: organic chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically to a particular 9-ethyl-6,6-dimethyl-8-(4-morpholine-4-yl-piperidine-1-yl)-11-oxo-6,11-dihydro-5H-dihydro-5H-benzo [b]carbazole-3-carbonitrile . Invention also relates to a medicament, an ALK inhibitor and pharmaceutical composition based on particular benzo-carbazole derivative.
EFFECT: novel benzo-carbazole derivatives which are useful in treating cancer are obtained.
7 cl, 49 tbl, 1218 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRACYCLIC COMPOUNDS | 2010 |
|
RU2725140C2 |
| COMPOSITION CONTAINING TETRACYCLIC COMPOUNDS | 2011 |
|
RU2573392C2 |
| NEW PHARMACEUTICAL COMPOSITION CONTAINING NONIONIC SURFACTANTS | 2015 |
|
RU2720680C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
| TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
| SULPHONAMIDE COMPOUND OR SALT THEREOF | 2017 |
|
RU2732572C2 |
| ANTITUMOR AGENT | 2018 |
|
RU2770824C2 |
| SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
| CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF | 2012 |
|
RU2586885C2 |
